{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:21:27Z","timestamp":1787826087280,"version":"build-2784847793"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011033","name":"MEC | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-118558RB-I00"],"award-info":[{"award-number":["PID2020-118558RB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"MEC | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2017-82924-R"],"award-info":[{"award-number":["SAF2017-82924-R"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"MEC | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PDC2021-121102-I00"],"award-info":[{"award-number":["PDC2021-121102-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"MEC | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2023-147503OB-I00"],"award-info":[{"award-number":["PID2023-147503OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["2017-T2\/BMD6026"],"award-info":[{"award-number":["2017-T2\/BMD6026"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["SI4\/PJI\/2024-00219"],"award-info":[{"award-number":["SI4\/PJI\/2024-00219"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024134","name":"CIHR | Canadian Institutes of Health Research - Antimicrobial Resistance Research Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009794","name":"Breast Cancer Now","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017509","name":"CRUK | Cancer Research UK","doi-asserted-by":"publisher","award":["C33043\/A24478"],"award-info":[{"award-number":["C33043\/A24478"]}],"id":[{"id":"10.13039\/501100017509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["22-0329"],"award-info":[{"award-number":["22-0329"]}],"id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["EP\/X033392"],"award-info":[{"award-number":["EP\/X033392"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","award":["LCF\/BQ\/ES17\/11600007"],"award-info":[{"award-number":["LCF\/BQ\/ES17\/11600007"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["PRDMA21602GARC"],"award-info":[{"award-number":["PRDMA21602GARC"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunotherapy has reshaped melanoma treatment, yet the majority of patients fail to respond or develop resistance. Nerve growth factor receptor (NGFR\/p75NTR\/CD271) has been linked to melanoma aggressiveness and therapeutic resistance, but the underlying mechanisms remain unclear. Here, we demonstrate that pharmacologic inhibition of NGFR with THX-B significantly reduces distant metastasis and restores sensitivity in immunotherapy-resistant tumors. THX-B treatment also enhances intratumoral CD8\u207a T-cell infiltration. Further, we show that immune-resistant melanomas acquire an invasive, ameboid phenotype characterized by elevated NGFR, PD-L1, and activation of non-muscle myosin light chain 2 (NM II; MLC2). Mechanistically, NGFR regulates RhoA\/ROCK-dependent MLC2 phosphorylation and proteasomal stabilization. Analysis of melanoma patient samples reveals that high NGFR expression correlates with reduced progression-free survival following immunotherapy. Moreover, NGFR and phosphorylated MLC2 are consistently enriched at the invasive fronts of primary tumors, metastases, and in immunotherapy-resistant cell lines from melanoma patients. Altogether, these findings identify the NGFR\u2013MLC2 axis as a\u00a0mediator of invasive immune resistance and support NGFR inhibition as a strategy to enhance immunotherapy efficacy.<\/jats:p>","DOI":"10.1038\/s44318-026-00803-2","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T09:02:21Z","timestamp":1779786141000},"page":"4988-5023","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["NGFR induces melanoma invasion and immunotherapy resistance through myosin light chain 2 modulation"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-4430","authenticated-orcid":false,"given":"Laura","family":"Nogu\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9563-379X","authenticated-orcid":false,"given":"Vanesa","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3193-0783","authenticated-orcid":false,"given":"Juan","family":"Garc\u00eda-Agullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-0245","authenticated-orcid":false,"given":"Susana","family":"Garc\u00eda-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-4388","authenticated-orcid":false,"given":"Oscar","family":"Maiques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1590-5107","authenticated-orcid":false,"given":"Alberto","family":"Hern\u00e1ndez-Barranco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina S","family":"Mazariegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"P\u00e9rez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9606-0398","authenticated-orcid":false,"given":"Ra\u00fal","family":"Torres-Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Saltari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3695-8264","authenticated-orcid":false,"given":"Patrick","family":"Turko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7246-7951","authenticated-orcid":false,"given":"Mar\u00eda","family":"Mannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-4831","authenticated-orcid":false,"given":"Ali","family":"Nejatie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Nassour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0755-0518","authenticated-orcid":false,"given":"Diego","family":"Meg\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Peset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3249-6595","authenticated-orcid":false,"given":"Carmen","family":"Blanco-Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2230-7794","authenticated-orcid":false,"given":"Sonia","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5902-9420","authenticated-orcid":false,"given":"Mitchell","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6884-8815","authenticated-orcid":false,"given":"H Uri","family":"Saragovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5096-9456","authenticated-orcid":false,"given":"Victoria","family":"Sanz-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4256-3413","authenticated-orcid":false,"given":"H\u00e9ctor","family":"Peinado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"803_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1172\/JCI200420174","volume":"114","author":"S Acharyya","year":"2004","unstructured":"Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, Guttridge DC (2004) Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 114:370\u2013378","journal-title":"J Clin Invest"},{"key":"803_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ijc.32132","volume":"145","author":"P Arnaud-Coffin","year":"2019","unstructured":"Arnaud-Coffin P, Maillet D, Gan HK, Stelmes JJ, You B, Dalle S, Peron J (2019) A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors. Int J Cancer 145:639\u2013648","journal-title":"Int J Cancer"},{"key":"803_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41568-019-0154-4","volume":"19","author":"I Arozarena","year":"2019","unstructured":"Arozarena I, Wellbrock C (2019) Phenotype plasticity as enabler of melanoma progression and therapy resistance. Nat Rev Cancer 19:377\u2013391","journal-title":"Nat Rev Cancer"},{"key":"803_CR4","doi-asserted-by":"publisher","first-page":"39392","DOI":"10.1074\/jbc.M110.147801","volume":"285","author":"Y Bai","year":"2010","unstructured":"Bai Y, Dergham P, Nedev H, Xu J, Galan A, Rivera JC, ZhiHua S, Mehta HM, Woo SB, Sarunic MV et al (2010) Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism. J Biol Chem 285:39392\u201339400","journal-title":"J Biol Chem"},{"key":"803_CR5","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199\u20136206","journal-title":"J Clin Oncol"},{"key":"803_CR6","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3389\/fimmu.2017.00981","volume":"8","author":"J Bandola","year":"2017","unstructured":"Bandola J, Richter C, Ryser M, Jamal A, Ashton MP, von Bonin M, Kuhn M, Dorschner B, Alexopoulou D, Navratiel K et al (2017) Neurotrophin receptor p75NTR regulates immune function of plasmacytoid dendritic cells. Front Immunol 8:981","journal-title":"Front Immunol"},{"key":"803_CR7","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1111\/j.1460-9568.2004.03692.x","volume":"20","author":"A Blochl","year":"2004","unstructured":"Blochl A, Blumenstein L, Ahmadian MR (2004) Inactivation and activation of Ras by the neurotrophin receptor p75. Eur J Neurosci 20:2321\u20132335","journal-title":"Eur J Neurosci"},{"key":"803_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nature09161","volume":"466","author":"AD Boiko","year":"2010","unstructured":"Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, Butler PD, Yang GP, Joshua B, Kaplan MJ et al (2010) Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466:133\u2013137","journal-title":"Nature"},{"key":"803_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17739-8","volume":"11","author":"J Boshuizen","year":"2020","unstructured":"Boshuizen J, Vredevoogd DW, Krijgsman O, Ligtenberg MA, Blankenstein S, de Bruijn B, Frederick DT, Kenski JCN, Parren M, Bruggemann M et al (2020) Reversal of pre-existing NGFR-driven tumor and immune therapy resistance. Nat Commun 11:3946","journal-title":"Nat Commun"},{"key":"803_CR10","doi-asserted-by":"publisher","first-page":"e002435","DOI":"10.1136\/jitc-2021-002435","volume":"9","author":"JR Brahmer","year":"2021","unstructured":"Brahmer JR, Abu-Sbeih H, Ascierto PA, Brufsky J, Cappelli LC, Cortazar FB, Gerber DE, Hamad L, Hansen E, Johnson DB et al (2021) Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. J Immunother Cancer 9:e002435","journal-title":"J Immunother Cancer"},{"key":"803_CR11","doi-asserted-by":"crossref","unstructured":"Bruno F, Abondio P, Montesanto A, Luiselli D, Bruni AC, Maletta R (2023) The nerve growth factor receptor (NGFR\/p75(NTR)): a major player in alzheimer\u2019s disease. Int J Mol Sci 24:3200","DOI":"10.3390\/ijms24043200"},{"key":"803_CR12","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1158\/0008-5472.CAN-10-3997","volume":"71","author":"G Civenni","year":"2011","unstructured":"Civenni G, Walter A, Kobert N, Mihic-Probst D, Zipser M, Belloni B, Seifert B, Moch H, Dummer R, van den Broek M et al (2011) Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res 71:3098\u20133109","journal-title":"Cancer Res"},{"key":"803_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/35020106","volume":"406","author":"EA Clark","year":"2000","unstructured":"Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406:532\u2013535","journal-title":"Nature"},{"key":"803_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102976","volume":"24","author":"CM de Winde","year":"2021","unstructured":"de Winde CM, George SL, Crosas-Molist E, Hari-Gupta Y, Arp AB, Benjamin AC, Millward LJ, Makris S, Carver A, Imperatore V et al (2021) Podoplanin drives dedifferentiation and amoeboid invasion of melanoma. iScience 24:102976","journal-title":"iScience"},{"key":"803_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06119-x","volume":"14","author":"J Fang","year":"2023","unstructured":"Fang J, Lu Y, Zheng J, Jiang X, Shen H, Shang X, Lu Y, Fu P (2023) Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications. Cell Death Dis 14:586","journal-title":"Cell Death Dis"},{"key":"803_CR16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/jnci\/57.5.1199","volume":"57","author":"IJ Fidler","year":"1976","unstructured":"Fidler IJ, Nicolson GL (1976) Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J Natl Cancer Inst 57:1199\u20131202","journal-title":"J Natl Cancer Inst"},{"key":"803_CR17","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/jid.2013.490","volume":"134","author":"J Furuta","year":"2014","unstructured":"Furuta J, Inozume T, Harada K, Shimada S (2014) CD271 on melanoma cell is an IFN-gamma-inducible immunosuppressive factor that mediates downregulation of melanoma antigens. J Invest Dermatol 134:1369\u20131377","journal-title":"J Invest Dermatol"},{"key":"803_CR18","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s43018-021-00272-y","volume":"2","author":"S Garcia-Silva","year":"2021","unstructured":"Garcia-Silva S, Benito-Martin A, Nogues L, Hernandez-Barranco A, Mazariegos MS, Santos V, Hergueta-Redondo M, Ximenez-Embun P, Kataru RP, Lopez AA et al (2021) Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism. Nat Cancer 2:1387\u20131405","journal-title":"Nat Cancer"},{"key":"803_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0079-6123(03)46002-0","volume":"146","author":"JJ Gentry","year":"2004","unstructured":"Gentry JJ, Barker PA, Carter BD (2004) The p75 neurotrophin receptor: multiple interactors and numerous functions. Prog Brain Res 146:25\u201339","journal-title":"Prog Brain Res"},{"key":"803_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2018.12.038","volume":"176","author":"M Georgouli","year":"2019","unstructured":"Georgouli M, Herraiz C, Crosas-Molist E, Fanshawe B, Maiques O, Perdrix A, Pandya P, Rodriguez-Hernandez I, Ilieva KM, Cantelli G et al (2019) Regional activation of myosin II in cancer cells drives tumor progression via a secretory cross-talk with the immune microenvironment. Cell 176:757\u2013774.e723","journal-title":"Cell"},{"key":"803_CR21","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.chembiol.2018.09.007","volume":"25","author":"ETH Goh","year":"2018","unstructured":"Goh ETH, Lin Z, Ahn BY, Lopes-Rodrigues V, Dang NH, Salim S, Berger B, Dymock B, Senger DL, Ibanez CF (2018) A small molecule targeting the transmembrane domain of death receptor p75(NTR) induces melanoma cell death and reduces tumor growth. Cell Chem Biol 25:1485\u20131494.e1485","journal-title":"Cell Chem Biol"},{"key":"803_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cell.2004.07.020","volume":"118","author":"P Gonczy","year":"2004","unstructured":"Gonczy P (2004) Myosin assembly: the power of multiubiquitylation. Cell 118:272\u2013274","journal-title":"Cell"},{"key":"803_CR23","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/ar.24238","volume":"302","author":"S Guo","year":"2019","unstructured":"Guo S, Zhang Y, Wei C, Shi L, Feng Y (2019) The E3 ubiquitin ligase MARCH8 regulates TNF-alpha-induced apoptosis in hippocampal neurons by targeting myosin light chain 2 for degradation. Anat Rec 302:2271\u20132278","journal-title":"Anat Rec"},{"key":"803_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s43018-021-00221-9","volume":"2","author":"L Haas","year":"2021","unstructured":"Haas L, Elewaut A, Gerard CL, Umkehrer C, Leiendecker L, Pedersen M, Krecioch I, Hoffmann D, Novatchkova M, Kuttke M et al (2021) Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma. Nat Cancer 2:693\u2013708","journal-title":"Nat Cancer"},{"key":"803_CR25","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1073\/pnas.0501718102","volume":"102","author":"BL Hempstead","year":"2005","unstructured":"Hempstead BL (2005) Coupling neurotrophins to cell migration through selective guanine nucleotide exchange factor activation. Proc Natl Acad Sci USA 102:5645\u20135646","journal-title":"Proc Natl Acad Sci USA"},{"key":"803_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113705","volume":"43","author":"A Hernandez-Barranco","year":"2024","unstructured":"Hernandez-Barranco A, Santos V, Mazariegos MS, Caleiras E, Nogues L, Mourcin F, Leonard S, Oblet C, Genebrier S, Rossille D et al (2024) NGFR regulates stromal cell activation in germinal centers. Cell Rep 43:113705","journal-title":"Cell Rep"},{"key":"803_CR27","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1091\/mbc.4.11.1205","volume":"4","author":"JL Herrmann","year":"1993","unstructured":"Herrmann JL, Menter DG, Hamada J, Marchetti D, Nakajima M, Nicolson GL (1993) Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. Mol Biol Cell 4:1205\u20131216","journal-title":"Mol Biol Cell"},{"key":"803_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fonc.2018.00178","volume":"8","author":"SA Hogan","year":"2018","unstructured":"Hogan SA, Levesque MP, Cheng PF (2018) Melanoma immunotherapy: next-generation biomarkers. Front Oncol 8:178","journal-title":"Front Oncol"},{"key":"803_CR29","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/2326-6066.CIR-16-0060","volume":"4","author":"B Homet Moreno","year":"2016","unstructured":"Homet Moreno B, Zaretsky JM, Garcia-Diaz A, Tsoi J, Parisi G, Robert L, Meeth K, Ndoye A, Bosenberg M, Weeraratna AT et al (2016) Response to programmed cell death-1 blockade in a murine melanoma syngeneic model requires costimulation, CD4, and CD8 T cells. Cancer Immunol Res 4:845\u2013857","journal-title":"Cancer Immunol Res"},{"key":"803_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-017-0454-2","volume":"6","author":"QN Hong","year":"2017","unstructured":"Hong QN, Pluye P, Bujold M, Wassef M (2017) Convergent and sequential synthesis designs: implications for conducting and reporting systematic reviews of qualitative and quantitative evidence. Syst Rev 6:61","journal-title":"Syst Rev"},{"key":"803_CR31","doi-asserted-by":"crossref","unstructured":"Huang F, Goncalves C, Bartish M, Remy-Sarrazin J, Issa ME, Cordeiro B, Guo Q, Emond A, Attias M, Yang W et al (2021) Inhibiting the MNK1\/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses. J Clin Invest 131:e140752","DOI":"10.1172\/JCI140752"},{"key":"803_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.568931","volume":"11","author":"K Hudson","year":"2020","unstructured":"Hudson K, Cross N, Jordan-Mahy N, Leyland R (2020) The extrinsic and intrinsic roles of pd-l1 and its receptor PD-1: implications for immunotherapy treatment. Front Immunol 11:568931","journal-title":"Front Immunol"},{"key":"803_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, Berent-Maoz B, Pang J, Chmielowski B, Cherry G et al (2016) Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 165:35\u201344","journal-title":"Cell"},{"key":"803_CR34","doi-asserted-by":"publisher","first-page":"e62002","DOI":"10.1371\/journal.pone.0062002","volume":"8","author":"T Imai","year":"2013","unstructured":"Imai T, Tamai K, Oizumi S, Oyama K, Yamaguchi K, Sato I, Satoh K, Matsuura K, Saijo S, Sugamura K et al (2013) CD271 defines a stem cell-like population in hypopharyngeal cancer. PLoS ONE 8:e62002","journal-title":"PLoS ONE"},{"key":"803_CR35","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1371\/journal.pbio.0050212","volume":"5","author":"AL Johnston","year":"2007","unstructured":"Johnston AL, Lun X, Rahn JJ, Liacini A, Wang L, Hamilton MG, Parney IF, Hempstead BL, Robbins SM, Forsyth PA et al (2007) The p75 neurotrophin receptor is a central regulator of glioma invasion. PLoS Biol 5:e212","journal-title":"PLoS Biol"},{"key":"803_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/bit.10655","volume":"83","author":"JM Kelm","year":"2003","unstructured":"Kelm JM, Timmins NE, Brown CJ, Fussenegger M, Nielsen LK (2003) Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 83:173\u2013180","journal-title":"Biotechnol Bioeng"},{"key":"803_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1126\/science.aan6877","volume":"359","author":"A Kong","year":"2018","unstructured":"Kong A, Thorleifsson G, Frigge ML, Vilhjalmsson BJ, Young AI, Thorgeirsson TE, Benonisdottir S, Oddsson A, Halldorsson BV, Masson G et al (2018) The nature of nurture: effects of parental genotypes. Science 359:424\u2013428","journal-title":"Science"},{"key":"803_CR38","first-page":"913","volume":"72","author":"JM Kozlowski","year":"1984","unstructured":"Kozlowski JM, Hart IR, Fidler IJ, Hanna N (1984) A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst 72:913\u2013917","journal-title":"J Natl Cancer Inst"},{"key":"803_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nature11538","volume":"490","author":"J Landsberg","year":"2012","unstructured":"Landsberg J, Kohlmeyer J, Renn M, Bald T, Rogava M, Cron M, Fatho M, Lennerz V, Wolfel T, Holzel M et al (2012) Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 490:412\u2013416","journal-title":"Nature"},{"key":"803_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc8825","volume":"9","author":"J Lehmann","year":"2023","unstructured":"Lehmann J, Caduff N, Krzywinska E, Stierli S, Salas-Bastos A, Loos B, Levesque MP, Dummer R, Stockmann C, Munz C et al (2023) Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma. Sci Adv 9:eadc8825","journal-title":"Sci Adv"},{"key":"803_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/celldisc.2015.30","volume":"1","author":"A Lehraiki","year":"2015","unstructured":"Lehraiki A, Cerezo M, Rouaud F, Abbe P, Allegra M, Kluza J, Marchetti P, Imbert V, Cheli Y, Bertolotto C et al (2015) Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib. Cell Discov 1:15030","journal-title":"Cell Discov"},{"key":"803_CR42","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41591-021-01331-8","volume":"27","author":"D Liu","year":"2021","unstructured":"Liu D, Lin JR, Robitschek EJ, Kasumova GG, Heyde A, Shi A, Kraya A, Zhang G, Moll T, Frederick DT et al (2021) Evolution of delayed resistance to immunotherapy in a melanoma responder. Nat Med 27:985\u2013992","journal-title":"Nat Med"},{"key":"803_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06697-4","volume":"15","author":"Z Mai","year":"2024","unstructured":"Mai Z, Lin Y, Lin P, Zhao X, Cui L (2024) Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Cell Death Dis 15:307","journal-title":"Cell Death Dis"},{"key":"803_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56299-7","volume":"16","author":"O Maiques","year":"2025","unstructured":"Maiques O, Sallan MC, Laddach R, Pandya P, Varela A, Crosas-Molist E, Barcelo J, Courbot O, Liu Y, Graziani V et al (2025) Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis. Nat Commun 16:1394","journal-title":"Nat Commun"},{"key":"803_CR45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/exd.14423","volume":"31","author":"O Maiques","year":"2022","unstructured":"Maiques O, Sanz-Moreno V (2022) Location, location, location: melanoma cells \u201cliving at the edge\u201d. Exp Dermatol 31:82\u201388","journal-title":"Exp Dermatol"},{"key":"803_CR46","doi-asserted-by":"publisher","first-page":"e1008639","DOI":"10.1371\/journal.pgen.1008639","volume":"16","author":"SN Manivannan","year":"2020","unstructured":"Manivannan SN, Darouich S, Masmoudi A, Gordon D, Zender G, Han Z, Fitzgerald-Butt S, White P, McBride KL, Kharrat M et al (2020) Novel frameshift variant in MYL2 reveals molecular differences between dominant and recessive forms of hypertrophic cardiomyopathy. PLoS Genet 16:e1008639","journal-title":"PLoS Genet"},{"key":"803_CR47","first-page":"87","volume":"7","author":"D Marchetti","year":"1995","unstructured":"Marchetti D, McCutcheon I, Ross M, Nicolson G (1995) Inverse expression of neurotrophins and neurotrophin receptors at the invasion front of human-melanoma brain metastases. Int J Oncol 7:87\u201394","journal-title":"Int J Oncol"},{"key":"803_CR48","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.3390\/ijms23084260","volume":"23","author":"M Marsland","year":"2022","unstructured":"Marsland M, Dowdell A, Jiang CC, Wilmott JS, Scolyer RA, Zhang XD, Hondermarck H, Faulkner S (2022) Expression of NGF\/proNGF and their receptors TrkA, p75(NTR) and sortilin in melanoma. Int J Mol Sci 23:4260","journal-title":"Int J Mol Sci"},{"key":"803_CR49","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-20-0700","volume":"26","author":"R McLeod","year":"2020","unstructured":"McLeod R, Kumar R, Papadatos-Pastos D, Mateo J, Brown JS, Garces AHI, Ruddle R, Decordova S, Jueliger S, Ferraldeschi R et al (2020) First-in-human study of AT13148, a dual ROCK-AKT inhibitor in patients with solid tumors. Clin Cancer Res 26:4777\u20134784","journal-title":"Clin Cancer Res"},{"key":"803_CR50","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/pcmr.12498","volume":"29","author":"K Meeth","year":"2016","unstructured":"Meeth K, Wang JX, Micevic G, Damsky W, Bosenberg MW (2016) The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations. Pigment Cell Melanoma Res 29:590\u2013597","journal-title":"Pigment Cell Melanoma Res"},{"key":"803_CR51","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1158\/2159-8290.CD-17-1178","volume":"8","author":"A Mehta","year":"2018","unstructured":"Mehta A, Kim YJ, Robert L, Tsoi J, Comin-Anduix B, Berent-Maoz B, Cochran AJ, Economou JS, Tumeh PC, Puig-Saus C et al (2018) Immunotherapy resistance by inflammation-induced dedifferentiation. Cancer Discov 8:935\u2013943","journal-title":"Cancer Discov"},{"key":"803_CR52","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s00432-018-2726-1","volume":"144","author":"H Mishra","year":"2018","unstructured":"Mishra H, Mishra PK, Ekielski A, Jaggi M, Iqbal Z, Talegaonkar S (2018) Melanoma treatment: from conventional to nanotechnology. J Cancer Res Clin Oncol 144:2283\u20132302","journal-title":"J Cancer Res Clin Oncol"},{"key":"803_CR53","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2019.07.011","volume":"461","author":"S Morita","year":"2019","unstructured":"Morita S, Mochizuki M, Wada K, Shibuya R, Nakamura M, Yamaguchi K, Yamazaki T, Imai T, Asada Y, Matsuura K et al (2019) Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells. Cancer Lett 461:144\u2013152","journal-title":"Cancer Lett"},{"key":"803_CR54","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.celrep.2016.07.004","volume":"16","author":"M Ngo","year":"2016","unstructured":"Ngo M, Han A, Lakatos A, Sahoo D, Hachey SJ, Weiskopf K, Beck AH, Weissman IL, Boiko AD (2016) Antibody therapy targeting CD47 and CD271 effectively suppresses melanoma metastasis in patient-derived xenografts. Cell Rep 16:1701\u20131716","journal-title":"Cell Rep"},{"key":"803_CR55","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1158\/2159-8290.CD-21-1357","volume":"12","author":"AJ Nirmal","year":"2022","unstructured":"Nirmal AJ, Maliga Z, Vallius T, Quattrochi B, Chen AA, Jacobson CA, Pelletier RJ, Yapp C, Arias-Camison R, Chen YA et al (2022) The spatial landscape of progression and immunoediting in primary melanoma at single-cell resolution. Cancer Discov 12:1518\u20131541","journal-title":"Cancer Discov"},{"key":"803_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ccell.2019.12.003","volume":"37","author":"JL Orgaz","year":"2020","unstructured":"Orgaz JL, Crosas-Molist E, Sadok A, Perdrix-Rosell A, Maiques O, Rodriguez-Hernandez I, Monger J, Mele S, Georgouli M, Bridgeman V et al (2020) Myosin II reactivation and cytoskeletal remodeling as a hallmark and a vulnerability in melanoma therapy resistance. Cancer Cell 37:85\u2013103.e109","journal-title":"Cancer Cell"},{"key":"803_CR57","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrc.2016.123","volume":"17","author":"CD Paul","year":"2017","unstructured":"Paul CD, Mistriotis P, Konstantopoulos K (2017) Cancer cell motility: lessons from migration in confined spaces. Nat Rev Cancer 17:131\u2013140","journal-title":"Nat Rev Cancer"},{"key":"803_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.306","volume":"8","author":"M Platon-Corchado","year":"2017","unstructured":"Platon-Corchado M, Barcelona PF, Jmaeff S, Marchena M, Hernandez-Pinto AM, Hernandez-Sanchez C, Saragovi HU, de la Rosa EJ (2017) p75(NTR) antagonists attenuate photoreceptor cell loss in murine models of retinitis pigmentosa. Cell Death Dis 8:e2922","journal-title":"Cell Death Dis"},{"key":"803_CR59","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.semcancer.2019.08.001","volume":"59","author":"P Queirolo","year":"2019","unstructured":"Queirolo P, Boutros A, Tanda E, Spagnolo F, Quaglino P (2019) Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy. Semin Cancer Biol 59:290\u2013297","journal-title":"Semin Cancer Biol"},{"key":"803_CR60","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/exd.12683","volume":"24","author":"MI Raaijmakers","year":"2015","unstructured":"Raaijmakers MI, Widmer DS, Maudrich M, Koch T, Langer A, Flace A, Schnyder C, Dummer R, Levesque MP (2015) A new live-cell biobank workflow efficiently recovers heterogeneous melanoma cells from native biopsies. Exp Dermatol 24:377\u2013380","journal-title":"Exp Dermatol"},{"key":"803_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10129-z","volume":"7","author":"J Radke","year":"2017","unstructured":"Radke J, Rossner F, Redmer T (2017) CD271 determines migratory properties of melanoma cells. Sci Rep 7:9834","journal-title":"Sci Rep"},{"key":"803_CR62","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1101\/gad.329771.119","volume":"33","author":"F Rambow","year":"2019","unstructured":"Rambow F, Marine JC, Goding CR (2019) Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities. Genes Dev 33:1295\u20131318","journal-title":"Genes Dev"},{"key":"803_CR63","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","volume":"174","author":"F Rambow","year":"2018","unstructured":"Rambow F, Rogiers A, Marin-Bejar O, Aibar S, Femel J, Dewaele M, Karras P, Brown D, Chang YH, Debiec-Rychter M et al (2018) Toward minimal residual disease-directed therapy in melanoma. Cell 174:843\u2013855.e819","journal-title":"Cell"},{"key":"803_CR64","doi-asserted-by":"publisher","first-page":"e92596","DOI":"10.1371\/journal.pone.0092596","volume":"9","author":"T Redmer","year":"2014","unstructured":"Redmer T, Welte Y, Behrens D, Fichtner I, Przybilla D, Wruck W, Yaspo ML, Lehrach H, Schafer R, Regenbrecht CR (2014) The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells. PLoS ONE 9:e92596","journal-title":"PLoS ONE"},{"key":"803_CR65","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s42255-023-00861-4","volume":"5","author":"M Redondo-Munoz","year":"2023","unstructured":"Redondo-Munoz M, Rodriguez-Baena FJ, Aldaz P, Caballe-Mestres A, Moncho-Amor V, Otaegi-Ugartemendia M, Carrasco-Garcia E, Olias-Arjona A, Lasheras-Otero I, Santamaria E et al (2023) Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy. Nat Metab 5:1544\u20131562","journal-title":"Nat Metab"},{"key":"803_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01573-6","volume":"8","author":"G Restivo","year":"2017","unstructured":"Restivo G, Diener J, Cheng PF, Kiowski G, Bonalli M, Biedermann T, Reichmann E, Levesque MP, Dummer R, Sommer L (2017) Low neurotrophin receptor CD271 regulates phenotype switching in melanoma. Nat Commun 8:1988","journal-title":"Nat Commun"},{"key":"803_CR67","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz N, Havel JJ, Makarov V, Desrichard A, Urba WJ, Sims JS, Hodi FS, Martin-Algarra S, Mandal R, Sharfman WH et al (2017) Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell 171:934\u2013949.e916","journal-title":"Cell"},{"key":"803_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18951-2","volume":"11","author":"I Rodriguez-Hernandez","year":"2020","unstructured":"Rodriguez-Hernandez I, Maiques O, Kohlhammer L, Cantelli G, Perdrix-Rosell A, Monger J, Fanshawe B, Bridgeman VL, Karagiannis SN, Penin RM et al (2020) WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion. Nat Commun 11:5315","journal-title":"Nat Commun"},{"key":"803_CR69","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0301-0082(02)00016-3","volume":"67","author":"PP Roux","year":"2002","unstructured":"Roux PP, Barker PA (2002) Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 67:203\u2013233","journal-title":"Prog Neurobiol"},{"key":"803_CR70","doi-asserted-by":"crossref","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A (2021) Epidemiology of melanoma. Med Sci 9:63","DOI":"10.3390\/medsci9040063"},{"key":"803_CR71","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1158\/0008-5472.CAN-21-0117","volume":"81","author":"A Saltari","year":"2021","unstructured":"Saltari A, Dzung A, Quadri M, Tiso N, Facchinello N, Hernandez-Barranco A, Garcia-Silva S, Nogues L, Stoffel CI, Cheng PF et al (2021) Specific activation of the CD271 intracellular domain in combination with chemotherapy or targeted therapy inhibits melanoma progression. Cancer Res 81:6044\u20136057","journal-title":"Cancer Res"},{"key":"803_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi0244","volume":"9","author":"R Samain","year":"2023","unstructured":"Samain R, Maiques O, Monger J, Lam H, Candido J, George S, Ferrari N, KohIhammer L, Lunetto S, Varela A et al (2023) CD73 controls myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells. Sci Adv 9:eadi0244","journal-title":"Sci Adv"},{"key":"803_CR73","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.cell.2008.09.043","volume":"135","author":"V Sanz-Moreno","year":"2008","unstructured":"Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ (2008) Rac activation and inactivation control plasticity of tumor cell movement. Cell 135:510\u2013523","journal-title":"Cell"},{"key":"803_CR74","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682","journal-title":"Nat Methods"},{"key":"803_CR75","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2559.2008.03063.x","volume":"53","author":"TM Soland","year":"2008","unstructured":"Soland TM, Brusevold IJ, Koppang HS, Schenck K, Bryne M (2008) Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma. Histopathology 53:62\u201372","journal-title":"Histopathology"},{"key":"803_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling DR, Swain-Bowden MJ, Lucas AM, Carpenter AE, Cimini BA, Goodman A (2021) CellProfiler 4: improvements in speed, utility and usability. BMC Bioinformatics 22:433","journal-title":"BMC Bioinformatics"},{"key":"803_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg6686","volume":"9","author":"L Sun","year":"2023","unstructured":"Sun L, Kang X, Ju H, Wang C, Yang G, Wang R, Sun S (2023) A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options. Sci Adv 9:eadg6686","journal-title":"Sci Adv"},{"key":"803_CR78","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","volume":"17","author":"SC Sun","year":"2017","unstructured":"Sun SC (2017) The non-canonical NF-kappaB pathway in immunity and inflammation. Nat Rev Immunol 17:545\u2013558","journal-title":"Nat Rev Immunol"},{"key":"803_CR79","doi-asserted-by":"publisher","DOI":"10.1126\/science.abp8964","volume":"379","author":"TE Sutherland","year":"2023","unstructured":"Sutherland TE, Dyer DP, Allen JE (2023) The extracellular matrix and the immune system: a mutually dependent relationship. Science 379:eabp8964","journal-title":"Science"},{"key":"803_CR80","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1200\/JCO.2013.53.0105","volume":"32","author":"SL Topalian","year":"2014","unstructured":"Topalian SL, Sznol M, McDermott DF, Kluger HM, Carvajal RD, Sharfman WH, Brahmer JR, Lawrence DP, Atkins MB, Powderly JD et al (2014) Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J Clin Oncol 32:1020\u20131030","journal-title":"J Clin Oncol"},{"key":"803_CR81","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.stemcr.2017.04.014","volume":"8","author":"R Torres-Ruiz","year":"2017","unstructured":"Torres-Ruiz R, Martinez-Lage M, Martin MC, Garcia A, Bueno C, Castano J, Ramirez JC, Menendez P, Cigudosa JC, Rodriguez-Perales S (2017) Efficient recreation of t(11;22) EWSR1-FLI1(+) in human stem cells using CRISPR\/Cas9. Stem Cell Rep 8:1408\u20131420","journal-title":"Stem Cell Rep"},{"key":"803_CR82","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1083\/jcb.150.4.797","volume":"150","author":"G Totsukawa","year":"2000","unstructured":"Totsukawa G, Yamakita Y, Yamashiro S, Hartshorne DJ, Sasaki Y, Matsumura F (2000) Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol 150:797\u2013806","journal-title":"J Cell Biol"},{"key":"803_CR83","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1126\/science.1090772","volume":"302","author":"HR Wang","year":"2003","unstructured":"Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH, Wrana JL (2003) Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 302:1775\u20131779","journal-title":"Science"},{"key":"803_CR84","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/pcmr.12591","volume":"30","author":"J Wang","year":"2017","unstructured":"Wang J, Perry CJ, Meeth K, Thakral D, Damsky W, Micevic G, Kaech S, Blenman K, Bosenberg M (2017) UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model. Pigment Cell Melanoma Res 30:428\u2013435","journal-title":"Pigment Cell Melanoma Res"},{"key":"803_CR85","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jmb.2005.05.021","volume":"350","author":"SH Witt","year":"2005","unstructured":"Witt SH, Granzier H, Witt CC, Labeit S (2005) MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J Mol Biol 350:713\u2013722","journal-title":"J Mol Biol"},{"key":"803_CR86","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/s41388-021-01691-y","volume":"40","author":"R Wu","year":"2021","unstructured":"Wu R, Li K, Yuan M, Luo KQ (2021) Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cells. Oncogene 40:2165\u20132281","journal-title":"Oncogene"},{"key":"803_CR87","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/1541-7786.MCR-07-0344","volume":"6","author":"L Xu","year":"2008","unstructured":"Xu L, Shen SS, Hoshida Y, Subramanian A, Ross K, Brunet JP, Wagner SN, Ramaswamy S, Mesirov JP, Hynes RO (2008) Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol Cancer Res 6:760\u2013769","journal-title":"Mol Cancer Res"},{"key":"803_CR88","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1083\/jcb.200202010","volume":"157","author":"T Yamashita","year":"2002","unstructured":"Yamashita T, Higuchi H, Tohyama M (2002) The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J Cell Biol 157:565\u2013570","journal-title":"J Cell Biol"},{"key":"803_CR89","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0896-6273(00)81114-9","volume":"24","author":"T Yamashita","year":"1999","unstructured":"Yamashita T, Tucker KL, Barde YA (1999) Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron 24:585\u2013593","journal-title":"Neuron"}],"container-title":["The EMBO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00803-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44318-026-00803-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00803-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:31:36Z","timestamp":1784097096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44318-026-00803-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":89,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7,15]]}},"alternative-id":["803"],"URL":"https:\/\/doi.org\/10.1038\/s44318-026-00803-2","relation":{},"ISSN":["1460-2075"],"issn-type":[{"value":"1460-2075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the Funding section of this article, the funder information was incorrectly given as Cancer Research UK Therapeutic Discovery Laboratories (CRUK-TDL) instead of Cancer Research UK (CRUK). This has now been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}